e-learning
resources
Munich 2014
Monday, 08.09.2014
Asthma or COPD: comorbid condition or a poorly understood single disease?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic nasal inflammation in asthmatic patients with eosinophilic granulomatosis with polyangitis (EGPA)
M. Latorre, V. Seccia, F. Novelli, C. Baldini, E. Bacci, M. L. Bartoli, S. Cianchetti, F. Dente, A. Di Franco, P. L. Paggiaro (Pisa, Italy)
Source:
International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Session:
Asthma or COPD: comorbid condition or a poorly understood single disease?
Session type:
Poster Discussion
Number:
1766
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Latorre, V. Seccia, F. Novelli, C. Baldini, E. Bacci, M. L. Bartoli, S. Cianchetti, F. Dente, A. Di Franco, P. L. Paggiaro (Pisa, Italy). Chronic nasal inflammation in asthmatic patients with eosinophilic granulomatosis with polyangitis (EGPA). Eur Respir J 2014; 44: Suppl. 58, 1766
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA)
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
Factors associated with irreversible airway obstruction in patients with asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Cognitive impairment in patients with eosinophilic granulomatosis with polyangiitis (EGPA): Service evaluation in a regional severe asthma centre in North-west England
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Phenotypic characteristics of asthma with small airways involvement
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Psychopathology in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Effects of beta-blockers on lung function in bronchial asthma patients
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Bronchiectasis is common in severe asthma
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Treating peripheral eosinophilia in asthma: Simple and effective
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Chronic cough in children: Is it asthma?
Source: International Congress 2014 – More paediatric asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept